Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

117.48
Delayed Data
As of Jan 13
 +0.40 / +0.34%
Today’s Change
93.05
Today|||52-Week Range
127.00
+1.49%
Year-to-Date
Donald Trump Just Leveled Drug Companies With These 4 Words
Jan 14 / MotleyFool.com - Paid Partner Content
The Monday Sights, Sounds and Biotech Buzz from the J.P. Morgan Healthcare Conference
Jan 09 / TheStreet.com - Paid Partner Content
Terra Nova Asset Management LLC Buys Goldman Sachs Group Inc, Ulta Salon Cosmetics & ...
Jan 13 / GuruFocus News - Paid Partner Content
Is Celgene Simply the Best Biotech Stock on the Planet?
Jan 09 / MotleyFool.com - Paid Partner Content
Terra Nova Asset Management LLC Buys Goldman Sachs Group Inc, Ulta Salon Cosmetics & ...
Jan 13 / GuruFocus News - Paid Partner Content
Celgene Sees Much Higher Profits, but Wall Street Still Yawns
Jan 09 / TheStreet.com - Paid Partner Content
CT Financial Advisors LLC Buys Alphabet Inc, Alphabet Inc, United Therapeutics Corp, ...
Jan 12 / GuruFocus News - Paid Partner Content
Here's a Biotech IPO You'll Want to Watch
Jan 09 / MotleyFool.com - Paid Partner Content
Trump Attacks Biotech & Pharma: ETFs Bleed
Jan 12 / Zacks.com - Paid Partner Content
Start the New Year off Right with 3 Best Biotech Stocks
Jan 08 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: ARIAD to be Acquired for $5.2B, Vertex Outlook Falls Short
Jan 11 / Zacks.com - Paid Partner Content
Top Stocks to Buy in 2017
Jan 07 / MotleyFool.com - Paid Partner Content
What's Next For Celgene
Jan 10 / MotleyFool.com - Paid Partner Content
Halozyme (HALO) Up on Positive Phase II Data on PEGPH20
Jan 06 / Zacks.com - Paid Partner Content
Why Agios Pharmaceuticals Sank 34.4% in 2016
Jan 10 / MotleyFool.com - Paid Partner Content
Bristol-Myers, J&J Ink Immunotherapy Research Collaboration
Jan 06 / Zacks.com - Paid Partner Content
Celgene Issues Preliminary 2016 Results, Lifts 2017 View
Jan 10 / Zacks.com - Paid Partner Content
Healthcare Stocks to Buy for 2017: Less Risky, More Risky, and Most Risky
Jan 05 / MotleyFool.com - Paid Partner Content
So the Nasdaq Is At a Historical High but the Dow Is Going Opposite Direction
Jan 09 / TheStreet.com - Paid Partner Content
Did Biogen Just Throw in the Towel to Celgene?
Jan 04 / MotleyFool.com - Paid Partner Content